Regenerative Medicine Market by Size, Share, Forecasts, & Trends Analysis

 Meticulous Research®, a prominent international market research firm, recently released a report titled Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, PRP, CAR T Cell, Tissue Engineering) Application (Oncology, Cardiovascular, Neurology, Immunology) End User (Hospital, ASC) — Global Forecast to 2031.

As per the most recent report by Meticulous Research®, the regenerative medicine market is anticipated to achieve a value of $78.53 billion by 2031, growing at a compound annual growth rate (CAGR) of 20% between 2024 and 2031. This expansion is attributed to several factors including the growing number of approvals for regenerative medicine, advancements in this field, a rise in the incidence of diseases targeted by these therapies, broader applications of regenerative medicine across various therapy areas, and increased funding for research and development. Nonetheless, challenges such as the high treatment costs and ethical considerations associated with stem cell usage could pose constraints on market growth.

Additionally, the growing interest in personalized medicine, escalating demand for organ transplants, and the expanding pipeline of products are anticipated to offer opportunities for market expansion. However, obstacles such as unfavorable reimbursement policies and manufacturing complexities are hindering the market's growth.

Key Players

The regenerative medicine market is populated by prominent players including Novartis AG (Switzerland), Biogen Inc. (U.S.), AstraZeneca plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Integra Life Sciences (U.S.), Sarepta Therapeutics, Inc. (U.S.), Bayer AG (Germany), Amgen Inc. (U.S.), CORESTEMCHEMON Inc. (South Korea), Smith & Nephew plc (U.K.), GSK plc (U.K.), Takeda Pharmaceutical Company Limited (Japan), Astellas Pharma (Japan), Medtronic plc (Ireland), AbbVie Inc. (U.S.), Bristol Myers Squibb (U.S.), Cook Group Incorporated (U.S.), Pfizer Inc. (U.S.), Merck KGaA (Germany), and Vericel (U.S.).

Regenerative Medicine Market: Future Outlook

The regenerative medicine market is categorized based on product types such as gene therapy, cell therapy (including stem cell therapy, platelet-rich plasma therapy, and cell-based immunotherapy), and tissue engineering. It is further segmented by applications including cardiovascular diseases, ophthalmic diseases, oncology, neurological diseases, immunology & inflammation, musculoskeletal diseases, dermatological diseases, and other applications. Additionally, the market is segmented by end users into hospitals & clinics and ambulatory surgical centers. The study thoroughly assesses competitors in the industry and provides analysis at both global and regional levels.

Among the products covered in this report, the gene therapy sector is forecasted to experience the highest growth rate from 2024 to 2031. This growth is driven by the increasing adoption of gene therapies in the treatment of various diseases like cancer, immunodeficiency disorders, cystic fibrosis, and diabetes. Gene therapy involves the introduction of new copies of a defective gene or the replacement of a faulty gene entirely. Advancements in genetic engineering technologies, such as CRISPR CAS, are further enhancing the efficacy of gene therapy by enabling precise genome alterations in a shorter timeframe. For example, the U.K. government has approved the use of CRISPR–Cas9 gene editing therapy for sickle cell anemia treatment. Additionally, there's a notable focus from manufacturers on developing gene therapy products. According to data from the Alliance for Regenerative Medicine, as of the third quarter of 2023, 556 manufacturers in North America and 209 in Europe were actively involved in the development of gene therapy products.

Among the applications covered in this report, in 2024, the oncology segment is expected to dominate the regenerative medicine market. This dominance is driven by several factors, including the significant global burden of cancer, a rising research emphasis on using regenerative medicine for cancer treatment, increasing approvals of regenerative medicine products specifically for oncology applications, a growing number of clinical trials in this area, and the escalating public-private funding aimed at advancing oncology treatments. For example, in March 2023, researchers at the University of California were granted a USD 5.7 million from the California Institute of Regenerative Medicine to support their efforts in advancing stem cell therapy for cancer treatment.

Among the end users covered in this report, by 2024, the hospitals & clinics segment is forecasted to hold the majority share of the regenerative medicine market. This dominance can be credited to several factors, including the growing number of both public and private hospitals, the rising incidence of chronic diseases resulting in increased hospital admissions, and the expanding availability of regenerative medicine therapies within hospital settings. Furthermore, the existence of reimbursement policies for regenerative medicine procedures performed at hospitals adds to the segment's significant market share.

Geographic Review:

The research report examines key geographical regions and offers a thorough analysis of the market across various areas including North America (comprising the U.S. and Canada), Europe (encompassing Germany, France, the U.K., Italy, Spain, Switzerland, Netherlands, Sweden, and the Rest of Europe), Asia-Pacific (including China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), Latin America (comprising Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa.

Among the regions analyzed in this report, the Asia-Pacific market is anticipated to demonstrate the most significant growth rate throughout the forecast period. This growth is fueled by proactive government efforts aimed at fostering the development of regenerative medicine and by increased funding for research endeavors. Governments in countries like India, Australia, and South Korea are actively offering research grants to bolster advancements in regenerative medicine, thereby fostering opportunities for market expansion. As an example, India's Department of Biotechnology allocated a fund of USD 9.35 million over a four-year period from 2019 to 2022 to support research in this domain.

Additionally, the affordability of stem cell therapy in nations like India, in contrast to North America and Europe, is drawing medical tourists and stimulating the demand for regenerative medicine. According to reports from Medical Tourism Corporation in India, the cost of stem cell therapy in the country is roughly 25% lower than that in Western nations, rendering it a more cost-effective choice for patients in need of such treatments.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5864

Key questions answered in the report-

  • What are the market segments showing significant growth potential in terms of product, application, end user, and region/country?
  • What was the past global market size of the regenerative medicine market?
  • What are the projected market forecasts and estimations for the period spanning from 2024 to 2031?
  • What are the primary factors propelling, hindering, challenging, offering opportunities, and shaping trends within the regenerative medicine market?
  • Who are the key players in the regenerative medicine market?
  • What does the competitive scenario look like, and who are the leading players in the regenerative medicine market?
  • What are the latest advancements or updates in the regenerative medicine market?
  • What are the various approaches employed by the key players in the regenerative medicine market?
  • What are the trends observed in different geographical regions and which regions or countries show significant growth potential?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Comments

Post a Comment

Popular posts from this blog

The Power Players: 15 Influencing Micro-mobility Market Growth

  The newly published research report on   Micro-mobility Market Report   provides an in-depth comprehension of a rapidly growing market. It offers an extensive market outlook, covering all the major aspects such as Micro-mobility market share, size, trends, projected growth rate, and sales channels. Also, it examines the challenges, opportunities, and prospects for the market. An in-depth analysis of all the major market segments and regions has been provided in the report. Pictorial representations such as tables, graphs, and charts have also been used to help readers comprehend the information easily. Both quantitative and qualitative research methodologies have been used in the study to provide an in-depth market comprehension. It covers crucial information on supply chain challenges and how businesses can deal with them. The research report is a vital resource for stakeholders, investors, and anyone looking to develop effective marketing strategies and stay ahead of ...
Read more

Europe EV Battery Market - Opportunity Analysis And Industry Forecast (2022-2029)

  Meticulous Research®, a prominent market research firm, released a report titled " Europe EV Batteries Market  by Type (Li-ion, Ni-MH, SLA, Ultracapacitors, Solid-state Batteries), Capacity (<50 kWh, 51-100 kWh, 101-300 kWh, >300 kWh), Bonding Type (Wire, Laser), Form, Application, End User, and Country - Forecast to 2029" . The European EV battery market is projected to expand at a compound annual growth rate (CAGR) of 45.8% from 2022, reaching $94.41 billion by 2029 . This growth is primarily fueled by the rising global adoption of electric vehicles, falling battery prices, and the increasing localization of battery production. Additionally, the expanding use of battery-as-a-service presents lucrative growth opportunities for market participants. However, the market's growth may be somewhat hindered by a potential shortage in lithium mining capacity. Additionally, safety concerns related to EV batteries pose a significant challenge to the expansion of t...
Read more

Ventilators Market to be Worth $13.23 Billion by 2031

  Meticulous Research®, a prominent market research firm, released a report titled, ‘ Ventilators Market by Product (Instrument, Catheter, Mask, Tube) Mobility (Intensive Care, Portable) Interface (Invasive, Non-invasive) Age Group (Adult, Neonatal) Mode (Volume, Pressure, Dual) End User (Hospital, ASC, Home Care) – Global Forecast to 2031’. Meticulous Research® predicts that the ventilators market will expand to $13.23 billion by 2031 , growing at a compound annual growth rate (CAGR) of 8.3% between 2024 and 2031. This growth is fuelled by several factors, including the increased availability of intensive care units (ICUs) and ICU beds, higher rates of respiratory diseases, urbanization leading to increased pollution, a growing elderly population, and more instances of preterm births. Nonetheless, obstacles such as the expensive nature of ventilators and the preference for alternative oxygenation therapies hinder market advancement. Rising demand for therapeutic devices for ho...
Read more